All Pathways
PediatricsEmergency

Pediatric Status Epilepticus (AES 2016)

Pediatric Status Epilepticus (AES 2016): Pediatric Convulsive Status Epilepticus → Stabilization (0-5 min) → First-Line: Benzodiazepine (5-10 min) → Sei...

Pathway Overview

10 steps

Algorithm Steps

10 total

  1. 01Start

    Pediatric Convulsive Status Epilepticus

    Seizure ≥5 minutes or 2+ seizures without recovery

  2. 02Action

    Stabilization (0-5 min)

    Initial stabilization measures

    • Time the seizure
    • ABCs: Position, suction, O2, monitor
    • Establish IV access (if possible)
    • Check glucose - treat if hypoglycemic
    • Place in recovery position if no IV yet
  3. 03Action

    First-Line: Benzodiazepine (5-10 min)

    Give benzodiazepine immediately

    • WITH IV ACCESS:
    • • Lorazepam 0.1 mg/kg IV (max 4 mg) - PREFERRED
    • • OR Diazepam 0.15-0.2 mg/kg IV (max 10 mg)
    • WITHOUT IV ACCESS:
    • • Midazolam 0.2 mg/kg IM (max 10 mg) - PREFERRED
    • • OR Diazepam 0.3-0.5 mg/kg PR (max 20 mg)
    • • OR Midazolam 0.2 mg/kg intranasal
  4. 04Decision

    Seizure Stopped?

    Reassess after 5 minutes

  5. 05Outcome

    Seizure Controlled

    Post-ictal care and monitoring

    • Monitor for recurrence
    • Complete workup: Labs, glucose, electrolytes
    • Consider LP if infection suspected
    • Obtain EEG when stable
    • Start maintenance AED as appropriate
    • Admit for observation
  6. 06Action

    Second Benzodiazepine Dose (10-15 min)

    Repeat benzodiazepine if seizure continues

    • Repeat same dose of first-line benzodiazepine
    • • Lorazepam 0.1 mg/kg IV (max 4 mg)
    • • OR Midazolam 0.2 mg/kg IM if no IV
    • Establish IV/IO access if not already done
  7. 07Decision

    Seizure Stopped?

    Reassess after second benzodiazepine

  8. Path rejoins step 05Shared downstream outcome
  9. 08Action

    Second-Line AED (15-30 min)

    Add antiepileptic drug for benzodiazepine-refractory SE

    • Choose ONE:
    • • Fosphenytoin 20 mg PE/kg IV (max 1500 mg PE)
    • - Infuse at 3 mg PE/kg/min (max 150 mg PE/min)
    • • OR Levetiracetam 40-60 mg/kg IV (max 4500 mg)
    • - Infuse over 15 minutes
    • • OR Valproate 40 mg/kg IV (max 3000 mg)
    • - Avoid if metabolic disease, hepatic failure
  10. 09Decision

    Seizure Stopped?

    Reassess after second-line AED

  11. Path rejoins step 05Shared downstream outcome
  12. 10Warning

    Refractory Status Epilepticus (>30 min)

    ICU-level care required

    • Prepare for intubation and continuous infusion
    • Continuous EEG monitoring if available
    • Options (consult neurology):
    • • Midazolam infusion: 0.2 mg/kg bolus, then 0.1-0.4 mg/kg/hr
    • • Pentobarbital: 5-15 mg/kg bolus, then 0.5-5 mg/kg/hr
    • • Propofol (>3 yrs): 1-2 mg/kg bolus, then 1-5 mg/kg/hr
    • • Ketamine: 1-2 mg/kg bolus, then 1-5 mg/kg/hr
    • Titrate to burst-suppression on EEG

Guideline Source

AES Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus 2016

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address neonatal seizures (different management)
  • Specific doses for refractory SE may vary by institution
  • EEG monitoring ideal but not always available emergently

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Pediatric Status Epilepticus (AES 2016)?

The Pediatric Status Epilepticus (AES 2016) is a emergency clinical algorithm for Pediatrics. It provides a structured decision tree to guide clinical decision-making, based on AES Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus 2016.

What guideline is the Pediatric Status Epilepticus (AES 2016) based on?

This algorithm is based on AES Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus 2016 (DOI: 10.5698/1535-7597-16.1.48).

What are the limitations of the Pediatric Status Epilepticus (AES 2016)?

Known limitations include: Does not address neonatal seizures (different management); Specific doses for refractory SE may vary by institution; EEG monitoring ideal but not always available emergently. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pediatric Status Epilepticus (AES 2016) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free